Medical Access and Reimbursement in Faroe Islands

Currently classified as a strictly controlled substance under international psychotropic scheduling and subject to active enforcement in the Faroe Islands; there is no authorized routine medical or reimbursed use outside of permitted, approved clinical research. Enforcement and prosecutions for importation/possession are reported in local courts and police communications. # #.

Currently classified as a strictly controlled substance under national drug laws and the 1971 Convention; there is no authorized medical or reimbursed access in routine care in the Faroe Islands, except possible inclusion in formally approved clinical trials. Local criminal cases involving MDMA importation and sentencing demonstrate active enforcement. # #.

Esketamine (intranasal Spravato) is a centrally authorized product in Europe (European Medicines Agency) for treatment‑resistant depression and is subject to restricted distribution and supervised administration requirements; this EMA authorisation establishes that esketamine is a recognized medicinal product in the European regulatory framework, but the Faroe Islands operate their own national/local medicine importation, hospital formularies and reimbursement decisions which determine local availability and funding. The EMA summary for Spravato outlines the authorised indication (adults with treatment‑resistant depression, used with an oral antidepressant) and the requirement for supervised administration in a clinic setting. #.

Practical implication for the Faroe Islands: individual hospitals or the Faroese health authority would need to include esketamine on a local formulary or approve importation/prescribing pathways for it to be available and reimbursed; there is no publicly available Faroese national policy document (accessible in open sources) that establishes a universal, reimbursed esketamine program equivalent to larger EU health systems. Where esketamine is used, reimbursement and patient access are typically conditional (specialist psychiatrist prescribing, supervised administration, and local funding decisions). #

Ketamine is an established anaesthetic and emergency medicine included on the WHO Model List of Essential Medicines and is routinely used in hospitals for anaesthesia, analgesia and emergency care; those medical uses are part of standard healthcare delivery and are provided/reimbursed through health services rather than as psychedelic therapy. #.

In the Faroe Islands, ketamine therefore exists as a licit medical product for approved clinical indications (e.g., anaesthesia) within the healthcare system; however, ketamine used specifically as a psychiatric 'ketamine‑assisted therapy' is not the same as routine anaesthetic use and would depend on local clinical governance, specialist prescribing, and reimbursement pathways. Reports of illicit imports and seizures underscore that non‑medical distribution is illegal and prosecuted. #.

Currently classified as a strictly controlled substance under international schedules and national drug laws; there is no authorised medical or reimbursed use in the Faroe Islands outside of approved clinical research. Active enforcement against importation/possession applies. # #.

Currently classified as a strictly controlled substance under international and national drug control frameworks with no authorised medical or reimbursed use in routine care in the Faroe Islands outside of approved clinical research. Enforcement actions for controlled substances are public and active. # #.

Currently classified as a strictly controlled substance under many national scheduling regimes and has no authorised medical or reimbursed use in the Faroe Islands outside of approved clinical research; travel to obtain ibogaine treatment abroad would not create a domestic reimbursement or legal pathway at home. # #.

The primary psychoactive component (DMT) is internationally controlled and, in the Faroe Islands, use/import/possession of DMT‑containing preparations (including ayahuasca) is not authorised outside approved research — there is therefore no reimbursed medical access and importation/use is subject to criminal enforcement. # #.

Mescaline and mescaline‑containing cacti are controlled in most jurisdictions under international and national law; in the Faroe Islands there is no authorised medical or reimbursed access for mescaline outside approved clinical research and possession/importation is criminalised. # #.

Members of the 2C family are internationally controlled and are treated as illegal substances in jurisdictions enforcing the 1971 Convention; there is no authorised medical or reimbursed use in the Faroe Islands outside of approved clinical research and law‑enforcement action against distribution/importation occurs. # #.